Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline pharmaceuticals sa-nv - atovaquone 750 mg/5 ml - oral suspension - 750 mg/5 ml - atovaquone 150 mg/ml - atovaquone

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atovaquone 250 mg; proguanil hydrochloride 100 mg - film-coated tablet - proguanil, combinations

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atovaquone 250 mg; proguanil hydrochloride 100 mg - film-coated tablet - proguanil, combinations

Malta - Inggris - Malta Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - film-coated tablet - atovaquone 250 mg proguanil hydrochloride 100 mg - antiprotozoals

Kanada - Inggris - Health Canada

glaxosmithkline inc - atovaquone - suspension - 750mg - atovaquone 750mg - miscellaneous antiprotozoals

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atovaquone, quantity: 250 mg - tablet, film coated - excipient ingredients: hyprolose; microcrystalline cellulose; povidone; sodium starch glycollate; magnesium stearate; macrogol 8000; colour - for the acute treatment of mild to moderate pneumocystis carinii pneumonia (pcp) (difference of alveolar and arterial oxygen tensions {(a-a)do2 } /- 60mmhg (8kpa) breathing room air) in adult patients with aids who are intolerant of trimethoprim/sulphamethoxazole therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atovaquone, quantity: 250 mg - tablet, film coated - excipient ingredients: hyprolose; microcrystalline cellulose; povidone; sodium starch glycollate; magnesium stearate; macrogol 8000; colour - for the acute treatment of mild to moderate pneumocystis carinii pneumonia (pcp) (difference of alveolar and arterial oxygen tensions {(a-a)do2 } /- 60mmhg (8kpa) breathing room air) in adult patients with aids who are intolerant of trimethoprim/sulphamethoxazole therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - atovaquone, quantity: 62.5 mg; proguanil hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: poloxamer; povidone; hyprolose; purified water; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate type a; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; iron oxide red; macrogol 400 - atovaquopro gh is indicated for:,? prophylaxis of plasmodium falciparum malaria in adults and children greater than or equal to 11 kg.,? treatment of plasmodium falciparum malaria in adults and children aged 3 years or older.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - atovaquone, quantity: 62.5 mg; proguanil hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: povidone; microcrystalline cellulose; poloxamer; purified water; hyprolose; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate; titanium dioxide; macrogol 8000; hypromellose; iron oxide red; macrogol 400 - atovaquopro gh is indicated for:,? prophylaxis of plasmodium falciparum malaria in adults and children greater than or equal to 11 kg.,? treatment of plasmodium falciparum malaria in adults and children aged 3 years or older.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - atovaquone, quantity: 62.5 mg; proguanil hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; poloxamer; hyprolose; magnesium stearate; povidone; purified water; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 8000; iron oxide red; macrogol 400 - atovaquopro lapl is indicated for:,? prophylaxis of plasmodium falciparum malaria in adults and children greater than or equal to 11 kg.,? treatment of plasmodium falciparum malaria in adults and children aged 3 years or older.